Subscribe
Launches
3 min read

A Wrinkly-Breed Skincare Brand Widens Its Wedge With a Tail-Cleaning Tool

Squishface, a skincare line focused entirely on wrinkly and brachycephalic breeds, added a tail-cleaning brush and is expanding into groomer, retailer, and vet distribution. The move trades mass-market reach for depth, trust, and lifetime value inside a die-hard ownership base.

Written by
The Underbite
Published on
July 7, 2026
A Wrinkly-Breed Skincare Brand Widens Its Wedge With a Tail-Cleaning Tool

Most pet grooming brands chase the whole dog and the whole market. Squishface built its business on the opposite bet, owning the folds, wrinkles, and hard-to-reach crevices of brachycephalic breeds, and its newest product deepens that wedge rather than broadening it. The launch is small on its own, but the strategy behind it is the part operators should study.

Squishface adds a tail brush to its fold-care line

Squishface introduced the Nub Brush, a grooming tool built for dogs with corkscrew, curled, or stacked tails that trap dirt, moisture, and buildup. The brush uses three rows of inward-angled bristles designed to reach into tail folds and lift debris that ordinary brushes miss. It is available now through Squishface.com and the brand's wholesale portal, with plans to roll out to independent retailers, groomers, and veterinarians.

The product slots into an existing line rather than opening a new one. Founded in 2017 and made in the USA, Squishface built its name on Wrinkle Paste, a water-repellent barrier cream for the facial folds of bulldogs, French bulldogs, pugs, and other short-nosed breeds, formulated without water, alcohol, or common allergens. That flagship has accumulated a large and loyal review base across Amazon and Chewy, and the catalog has since expanded into tear-stain care, ear cleaning, wipes, and paw and nose products. The tail brush is the latest adjacent item aimed at the same customer and the same set of anatomical problems.

Why owning a breed cohort beats going mass

The brush itself is not the story. The strategy is. Bulldogs, Frenchies, and pugs are among the most popular and most obsessed-over cohorts in the category, and their owners spend accordingly on the skin and hygiene problems those breeds are prone to. Those problems are chronic, breed-specific, and largely ignored by the majors, who build for the median dog and treat fold care as a rounding error. Squishface planted itself in that gap and has stayed there.

By shipping hyper-targeted tools like a tail brush instead of chasing mass-market shelf space, the brand trades reach for depth. A customer who trusts the wrinkle paste to solve a real, recurring problem is primed to buy the next adjacent product, because the brand has demonstrated it understands their dog in a way a general grooming line does not. That is how a niche brand compounds: not by widening the funnel, but by deepening trust, repeat purchase, and lifetime value inside a die-hard ownership base. Each new SKU raises the average order value and the switching cost at the same time.

The tradeoff is real. A single-use tail tool has a smaller addressable market than a mass-market brush, and a specialist brand caps its own ceiling by definition. But the position is defensible in a way volume plays rarely are. Owning a breed cohort the majors overlook, and becoming the default name that cohort reaches for, is a more durable moat than fighting for shelf space on price.

What sell-through will show

The signal to track is sell-through, not the launch. Watch whether the Nub Brush earns durable placement in the wholesale, groomer, and vet channels or lives as a novelty add-on to the hero products. The pro channels matter most: groomers and vets who recommend Squishface to brachycephalic owners function as a trusted distribution layer that consumer marketing cannot easily replicate.

The broader pattern is worth filing for anyone building a pet brand. Specialization around a specific, high-need cohort, then methodically expanding share of that customer's routine, is a quieter path than going mass, but it builds loyalty and margin that are hard to dislodge. Squishface's next few product moves will show whether the wedge keeps compounding or hits the natural limit of a niche.

Source: Submitted directly to The Underbite.

This news brief is based on a company-submitted announcement. The Underbite verifies claims where possible but cannot independently confirm all details.

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

What's Happening

Other News

More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.

Read article
Vetspire Splits From Thrive, Lands a Battery Ventures Backing
Funding & M&A
4 min read

Vetspire Splits From Thrive, Lands a Battery Ventures Backing

Vetspire has spun out of Thrive Pet Healthcare's orbit with a growth investment from Battery Ventures and a new CEO, Zachary Seely. The AI-powered practice management platform, used by more than 800 veterinary hospitals and clinics, will operate independently while Thrive remains a customer. The deal tests whether AI-native vet software can draw institutional capital without a strategic parent underwriting it.

Read article
Read article
PetMeds Revenue Falls 20% as Takeover Fight Drags On
Earnings
6 min read

PetMeds Revenue Falls 20% as Takeover Fight Drags On

PetMeds' first-quarter revenue fell 19.9% to $41.0 million and cash reserves dropped to $13.1 million, even as the company narrowed its net loss to $6.1 million from $34.2 million a year earlier. The results land as an unsolicited $3-a-share buyout offer from SilverCape Investments remains on the table and a $37 million sale-leaseback of its headquarters awaits closing.

Read article
Read article
FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North
Regulatory
4 min read

FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North

The FDA granted Zoetis an emergency use authorization for Simparica Trio to treat New World screwworm in dogs, the first product cleared specifically for the threat. Texas has already begun requiring treatment before dogs cross certain lines, putting boarding facilities, transporters, and border-state vet practices under a new compliance mandate.

Read article
View all articles